中华皮肤科杂志 ›› 2015, Vol. 48 ›› Issue (3): 179-183.

• 论著 • 上一篇    下一篇

白细胞介素22诱导HaCaT细胞表达肝素结合表皮生长因子样生长因子的作用机制探讨

刘欣欣1,罗素菊2,郑焱3,许文娟1,李颖1,刘全忠2   

  1. 1. 天津医科大学总医院
    2. 天津医科大学总医院皮肤性病科
    3. 西安交通大学第二医院皮肤科
  • 收稿日期:2014-04-24 修回日期:2014-10-30 发布日期:2015-02-26
  • 通讯作者: 罗素菊 E-mail:luosuju2005@163.com
  • 基金资助:

    Th22细胞干扰角质形成细胞分泌HB-EGF与其在银屑病发病中的作用探讨;线粒体损伤在银屑病 Th17 细胞分化及血管新生中的作用

Mechanisms underlying interleukin-22-induced expression of heparin-binding epidermal growth factor-like growth factor in HaCaT cells

  • Received:2014-04-24 Revised:2014-10-30 Published:2015-02-26

摘要:

目的 探讨白细胞介素22(IL-22)诱导HaCaT细胞表达肝素结合表皮生长因子样生长因子(HB-EGF)的相关作用机制。 方法 用不同浓度的IL-22(12.5、25、50、100 μg/L)干预处理HaCaT细胞,对照组选择等量磷酸盐缓冲液(PBS)处理。24 h后,提取HaCaT细胞总蛋白进行蛋白免疫印迹,检测丝裂原活化蛋白激酶-细胞外信号调节激酶1/2(MAPK-ERK1/2)通路中磷酸化ERK1/2(P-ERK1/2)的表达和转录激活因子途径(JAK/STAT)中磷酸化JAK2(P-JAK2)和磷酸化STAT3(P-STAT3)的表达。将HaCaT细胞分4组,分别用PBS、IL-22、MAPK-ERK1/2抑制剂PD98059、JAK2/STAT3通路抑制剂AG490与IL-22共同干预HaCaT细胞,24 h后,提取细胞总蛋白和总mRNA,分别用蛋白免疫印迹法和实时定量逆转录(RT)-PCR法检测不同处理组HB-EGF蛋白和mRNA水平的改变。采用SPSS16.0软件进行单因素方差分析检验组间差异,Bonferroni检验进行多重比较。结果 不同浓度的IL-22干预处理后,HaCaT细胞中P-ERK1/2、P-JAK2和P-STAT3蛋白表达均高于对照组(P < 0.05)。HB-EGF蛋白水平(HB-EGF/内参照的灰度比值)在PD98059组和AG490组分别为0.183 ± 0.020和0.199 ± 0.011,与IL-22组(0.924 ± 0.032)相比,差异具有统计学意义(F值分别为37.700、36.400,均P < 0.05)。HB-EGF mRNA水平在PD98059组和AG490组分别为1.034 ± 0.072和0.989 ± 0.038,与IL-22组(1.844 ± 0.135)相比,差异具有统计学意义(F值分别为11.271、13.429,均P < 0.05)。 结论 IL-22可以引起HaCaT细胞中MAPK-ERK1/2和JAK2/STAT3这两条信号通路激活。IL-22诱导HaCaT细胞产生HB-EGF蛋白的作用机制可能与MAPK-ERK1/2和JAK2/STAT3这两条信号通路有关。

Abstract:

Liu Xinxin*, Luo Suju, Zheng Yan, Xu Wenjuan, Li Ying, Liu Quanzhong. *Department of Dermatology, Tianjin Medical University General Hospital, Tianjin 300052, China Corresponding author: Luo Suju, Email: luosuju2005@163.com 【Abstract】 Objective To investigate the mechanisms underlying interleukin-22 (IL-22)-induced expression of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in HaCaT cells. Methods Some HaCaT cells were divided into several inverention groups treated with IL-22 at concentrations of 12.5, 25, 50, 100 μg/L, respectively and a control group treated with phosphate buffer saline (PBS). After 24-hour culture, total proteins were extracted from the HaCaT cells, and Western blot was performed to measure the expression of phosphorylated extracellular signal-regulated kinase 1/2 (P-ERK1/2) in the mitogen-activated protein kinase (MAPK)-ERK1/2 pathway, as well as phosphorylated-JAK2 (P-JAK2) and phosphorylated-signal transducer and activator of transcription 3 (P-STAT3) in the JAK2/STAT3 pathway. In a blocking experiment, some HaCaT cells were divided into 4 groups to be treated with PBS, IL-22, PD98059 (an inhibitor of MAPK-ERK1/2) combined with IL-22 (PD98059 group), AG490 (an inhibitor of JAK2/STAT3) combined with IL-22(AG490 group), respectively. After 24-hour treatment, total proteins and mRNAs were extracted from the HaCaT cells followed by Western blot and real-time quantitative reverse transcription-PCR for the measurement of protein and mRNA expressions of HB-EGF respectively. Statistical analysis was carried out with the software SPSS 16.0 by one-way analysis of variance (ANOVA) for intergroup comparisons and by Bonferroni′s test for multiple comparisons. Results After treatment with IL-22 at the above 4 concentrations, the expressions of P-ERK1/2, P-JAK2 and P-STAT3 in HaCaT cells were all increased compared with the control group (all P < 0.05). The protein and mRNA expression levels (expressed as the HB-EGF/β-actin ratio and 2-△△Ct respectively) of HB-EGF were both significantly decreased in the PD98059 group and AG490 group than in the IL-22 group (protein: 0.183 ± 0.020 and 0.199 ± 0.011 vs. 0.924 ± 0.032, F = 37.700, 36.400, respectively, both P < 0.05; mRNA: 1.034 ± 0.072 and 0.989 ± 0.038 vs. 1.844 ± 0.135, F = 11.271, 13.429, respectively, both P < 0.05). Conclusions IL-22 can activate the MAPK-ERK1/2 and JAK2/STAT3 signaling pathways in HaCaT cells, which may contribute to IL-22-induced expression of HB-EGF in HaCaT cells.

中图分类号: 

  • R-75

引用本文

刘欣欣 罗素菊 郑焱 许文娟 李颖 刘全忠. 白细胞介素22诱导HaCaT细胞表达肝素结合表皮生长因子样生长因子的作用机制探讨[J]. 中华皮肤科杂志, 2015,48(3):179-183. doi: